Which has grown faster, ORGO or PRQR?

Over the past five years, PRQR grew revenue faster — ORGO at a 1.05% CAGR versus PRQR at 94.34%.

How have ORGO and PRQR total returns compared?

Over the past 5 years, ORGO delivered -37.41% and PRQR delivered -26.23% annualized total return. Past performance doesn't predict future results.

Organogenesis Holdings Inc. (ORGO) vs ProQR Therapeutics N.V. (PRQR)

A side-by-side comparison of Organogenesis Holdings Inc. and ProQR Therapeutics N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ORGO

Organogenesis Holdings Inc.

$170M

$1.33HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

PRQR

ProQR Therapeutics N.V.

$173M

$1.65HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

Total return — ORGO vs PRQR

growth of $100 · dividends reinvested · last 10y

ORGO -86.8% (-18.3%/yr)PRQR -65.9% (-10.2%/yr)PRQR compounded faster over this window

ORGO PRQR

ORGO vs PRQR: by the numbers

•PRQR is the larger company ($173M vs $170M market cap).
•Both run net losses; ORGO's is the smaller (-19.76% vs -229.20% net margin).
•PRQR grew revenue faster over the past five years (94.34% vs 1.05% CAGR).

Metrics side by side

Valuation

Metric	ORGO	PRQR
P/S ratio	0.37	8.06
P/B ratio	1.15	1.91
EV / EBITDA	214.76	N/A
FCF yield	12.22%	N/A

Profitability

Metric	ORGO	PRQR
Gross margin	67.59%	83.01%
Operating margin	9.92%	-275.91%
Net margin	-19.76%	-229.20%
ROE	-31.32%	-54.27%
ROIC	-8.34%	-42.61%

Growth (annualized)

Metric	ORGO	PRQR
Revenue CAGR (5Y)	1.05%	94.34%
FCF CAGR (5Y)	-5.54%	N/A
Total return CAGR (5Y)	-37.41%	-26.23%

Frequently asked

Which has grown faster, ORGO or PRQR?: Over the past five years, PRQR grew revenue faster — ORGO at a 1.05% CAGR versus PRQR at 94.34%.
How have ORGO and PRQR total returns compared?: Over the past 5 years, ORGO delivered -37.41% and PRQR delivered -26.23% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ORGO analysis Full PRQR analysis Interactive comparison tool

Dig into the metrics

Organogenesis ROE ProQR Therapeutics ROE Organogenesis operating margin ProQR Therapeutics operating margin Organogenesis revenue growth ProQR Therapeutics revenue growth Organogenesis free cash flow ProQR Therapeutics free cash flow

Organogenesis & ProQR Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.